Readmission rate improvements often attributed to an Affordable Care Act policy fining hospitals with higher-than-expected readmissions may actually be the result of changes in how visits were being ...
For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more ...
Patients revisiting the hospital within 30 days of initial discharge increasingly receive care in emergency departments and observation stays, marking a shift that may reflect hospitals’ efforts to ...
In a study from Oxford University, researchers found that by using a combination of wearable sensor data and machine learning algorithms the progression of Parkinson’s disease can be monitored more ...
A phase 2 randomized, open-label, multicentre study of sintilimab and anlotinib in combination with gemcitabine plus cisplatin (GemCis) as first-line therapy in patients (pts) with advanced biliary ...
There is not a significant difference in harm risks between one week and two weeks of antibiotic use, according to a study published Dec. 30 in Clinical Infectious Diseases. Shorter antibiotic courses ...
Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC): Final results of the PRODIGE 5/ACCORD 17 trial. AURELIA: A ...
Men who’ve had COVID-19 may face hidden fertility risks. This study uncovers how the virus disrupts sperm health, even months after recovery. Study: COVID-19 infection was associated with poor sperm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results